Clinical Efficacyof Qufengzhitong Capsule in the Treatment of Knee Osteoarthritis and Its Effect on Inflammatory Cytokines

D. Zhao,Y. Bai,Y. Xi,C. Huang,Z. Wu,Q. Jiang,J. Gu,Y. Liu,X. Zuo,Z. Zhang
DOI: https://doi.org/10.1016/j.joca.2020.02.628
IF: 7.507
2020-01-01
Osteoarthritis and Cartilage
Abstract:Purpose: To explore the efficacy and safety of Qufengzhitong Capsule in the treatment of knee osteoarthritis and its effect on the expression of serum cytokine IL-1 and TNF-alpha. Methods: 180 patients with knee osteoarthritis were randomly divided into experimental group (120 cases) and control group (60 cases). Qufengzhitong Capsule was used for the experimental group, and the placebo was used for the control group. VAS was to evaluate the pain index of knee joint, while KOOS to evaluate the daily living ability and the knee of patients. ELISA was used to detect the expression of serum -1β(IL-1β) and TNF-αin before and after the experiment. Results: The effective rate of the experimental group was 71.03% after treatment, while that of the control group was 51.85%. This found a significant difference (P<0.05) between the effective rate of the experimental group and that of the control group. All indicators of KOOS were improved, with the significant differences in symptom score, sports score and entertainment ability score, and the life quality reladsvblmadmted to the knee (P < 0.05). The levels of serumIL-1β,TNF-α were all decreased in the experimental group, with a significant difference in the degree of IL-1β decrease (P<0.05). Conclusions: Qufengzhitong Capsule is effective in the treatment of chronic knee osteoarthritis and its mechanism may be related to the regulation of the expression of serum IL-1β and TNF-α of patients with chronic knee osteoarthritis.
What problem does this paper attempt to address?